Valuation dashboard for Achieve Life Sciences, Inc. (ACHV) with P/E N/A, P/B -48.65, EV/EBITDA -7.43 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
Achieve Life Sciences, Inc. operates as a clinical-stage pharmaceutical firm, concentrating on the development and market introduction of cytisinicline. This compound is aimed at assisting with smoking cessation and nicotine dependence, with commercial activities spanning Canada, the United States, and the United Kingdom.
Analysis Summary
Trailing-twelve-month margins: gross margin 0.0%, operating margin 0.0%, net margin 0.0%.
At the current price of $7.42, ACHV has negative trailing earnings (P/E not meaningful) and an ROE of -8.92%. Market capitalisation stands at $762M.
Balance sheet quality for ACHV: current ratio of 4.4. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | -48.65 |
| EV / EBITDA | -7.43 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $0.12 |
| vs Current Price | -98.4% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| ACHV | Achieve Life Sciences, Inc. | $762M | -8.9% | ||
| 0QZU.L | Vertex Pharmaceuticals Incorporated | $131.8B | |||
| VRTX | Vertex Pharmaceuticals Incorporated | $130.6B | 29.76 | 6.46 | 23.3% |
| 0R2M.L | Regeneron Pharmaceuticals, Inc. | $84.0B | |||
| REGN | Regeneron Pharmaceuticals, Inc. | $79.8B | 18.79 | 2.57 | 13.8% |
| ARGX | argenx SE | $61.2B | 36.30 | 7.40 | 21.7% |
| MRNA | Moderna, Inc. | $57.8B | 1.34 | -39.2% | |
| RVMD | Revolution Medicines, Inc. | $41.7B | 15.96 | -96.4% |
Price
| Price | $7.42 |
| Market Cap | $762M |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | -892.07% |
| Return on Invested Capital | -21425.74% |
| Return on Assets | -59.88% |
| Gross Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
Related companies: ALLO · ARCT · AVIR · CAPR · HUMA · IMRX · SGMT
Explore sector: Healthcare · Biotechnology
More sections of ACHV: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks